Dysvascular Amputation Self-Management of Health
Key facts
- Who runs it
- University of Colorado, Denver
- Where
- Aurora, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 35 people enrolled
- Started
- 1 Nov 2019
- Ended
- 31 May 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Walking Biobehavioral Intervention
- Attention Control
- Record updated
- 13 August 2026
Who can take part
- Age
- 50 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Within the age range of 50-85 years
- Confirmed diagnosis of Type II Diabetes Mellitus (DM) and/or Peripheral Artery Disease (PAD)
- Transtibial, knee disarticulation, or transfemoral lower-limb amputation (LLA) (or re-amputation) within the past 12 months
- Participant goal of household walking or better using a prosthesis
Who cannot take part
- Trauma or cancer-related etiology of the LLA
- Active cancer treatment
- Recent stroke (within 2 years)
- Decisionally challenged individuals (MMSE score below 24)
- Prisoners
- Clinical discretion of principal investigator to exclude patients who are determined to be unsafe and/or inappropriate to participate in the described intervention
Where in United States
- University of Colorado HospitalAurora, United States
About the trial
What the trial wants to find out
The purpose of this study is to determine if walking biobehavioral intervention improves physical activity after dysvascular lower limb amputation.
The 2 groups in the trial
- Walking Biobehavioral Intervention (EXP)Treatment being tested
The EXP group will receive biobehavioral training that is integrated into the conventional outpatient training component and is delivered over 5 months. There will be 10 biobehavioral sessions, 1 of which will be a combined biobehavioral/conventional outpatient session and the other 9 being telehealth sessions.
Treatment: Walking Biobehavioral Intervention
- Attention Control (CTL)Existing treatment, for comparison
The CTL group intervention will include the same conventional outpatient training (10 sessions) as the EXP group and receive the same computer tablets with telehealth software as the EXP group (week 3 of prosthetic training).
Treatment: Attention Control
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Improving Health Self-Management Using Walking Biobehavioral Intervention for People With Dysvascular Lower Limb Amputation
- Publications
- Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or diabetes.The Cochrane database of systematic reviews, 2023
- Record updated
- 13 August 2026